Chemours: High-Quality Chemicals Firm Trades Like Commodity Player

Chris McIntyre of McIntyre Partnerships presented his in-depth investment thesis on The Chemours Company (US: CC) at Best Ideas 2019.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

First name:

Last name:

Email address:

City / state / country:

Company:

How did you hear about MOI Global? Select Member referral Staff This website Media / Internet Other

If referral, please provide member's name:

Which of the following applies most closely to you? Select Investment Firm - Head Investment Firm - Analyst or PM Institutional Allocator - Firm C-Level Executive Institutional Allocator - Firm Employee Family Office - Head or Co-Owner Family Office - Employee Non-Investment Firm - C-Level Executive Non-Investment Firm - Employee Other

How do you hope to add value to the community?

Leave this field empty if you're human:

About the instructor:

Chris McIntyre is the founder of McIntyre Partnerships, a concentrated value fund located in New York City. He employees a selective-contrarian strategy focused on event driven, GARP, and distressed investments. Prior to founding McIntyre Partnerships, he was a Managing Director at MAK Capital, a value focused equity and credit fund, where he managed investments in consumer, telecom, and special situations. Prior to that, he was an analyst at several funds including Cobalt Capital and MDR Capital. Chris is a CFA charterholder. He is a University of Virginia graduate with degrees in Economics and Government.